Muller S J, Caradonna S
Department of Molecular Biology, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford 08084.
Biochim Biophys Acta. 1991 Feb 16;1088(2):197-207. doi: 10.1016/0167-4781(91)90055-q.
DNA repair of genetic information is an essential defense mechanism, which protects cells against mutation and transformation. The biochemistry of human DNA repair is in its beginning stages. Our research has concentrated on the enzymes involved in the removal of atypical bases from DNA. We present information on the identification and characterization of a cDNA isolate encoding uracil-DNA glycosylase. Uracil-DNA glycosylase was purified to homogeneity from HeLa S3 cells and used to generate polyclonal antibodies. These antibodies were in turn used to isolate a uracil-DNA glycosylase specific cDNA from a human T cell (Jurkat) lambda-gt11 library. The identity of this 1.25 kb cDNA was verified using in vitro transcription and translation systems to generate specific uracil-DNA glycosylase activity. Sequence data revealed a 327 amino acid open reading frame, which encodes a protein with a predicted molecular weight of 35351. No significant amino acid homology was found between this human uracil-DNA glycosylase and the glycosylases of yeast, Escherichia coli, herpes simplex virus, or a recently identified 26,000 Da species of human uracil-DNA glycosylase. This apparent lack of homology prompted an investigation of uracil-DNA glycosylase in a variety of eukaryotic species. Western analysis demonstrated the presence of a 36 kDa uracil-DNA glycosylase protein in human fibroblast, human placental and Vero cell extracts. Interestingly, these antibodies did not detect glycosylase protein in Chinese hamster ovary (CHO) or mouse NIH3T3 fibroblast cells. Under conditions of reduced stringency, Southern blot analysis of BamHI digested DNA from human fibroblasts, human placental cells and Vero cells revealed common 12 kb and 3 kb fragments. In contrast, using the same reduced stringency protocol, 6 and 8 kb fragments for CHO and NIH3T3 DNA were seen, respectively, as well as a common 3 kb fragment. Under more stringent wash conditions, the common 3 kb band was absent in all samples analyzed, and no hybridization signal was detected from DNA of hamster or mouse origin. The lack of immunological reactivity between the human uracil-DNA glycosylase and the rodent forms is therefore reflected at the genetic level as well. This distinction in human and CHO hybridization patterns enabled us to localize this human uracil-DNA glycosylase cDNA to chromosome 5 by somatic cell hybridization.
遗传信息的DNA修复是一种重要的防御机制,可保护细胞免受突变和转化。人类DNA修复的生物化学尚处于起步阶段。我们的研究集中在参与从DNA中去除非典型碱基的酶上。我们提供了关于一种编码尿嘧啶-DNA糖基化酶的cDNA分离物的鉴定和表征的信息。尿嘧啶-DNA糖基化酶从HeLa S3细胞中纯化至同质,并用于产生多克隆抗体。这些抗体继而被用于从人T细胞(Jurkat)λ-gt11文库中分离出尿嘧啶-DNA糖基化酶特异性cDNA。使用体外转录和翻译系统产生特异性尿嘧啶-DNA糖基化酶活性,验证了这个1.25 kb cDNA的身份。序列数据揭示了一个327个氨基酸的开放阅读框,其编码一种预测分子量为35351的蛋白质。在这种人类尿嘧啶-DNA糖基化酶与酵母、大肠杆菌、单纯疱疹病毒或最近鉴定的26000 Da的人类尿嘧啶-DNA糖基化酶的糖基化酶之间未发现明显的氨基酸同源性。这种明显的同源性缺乏促使对多种真核生物中的尿嘧啶-DNA糖基化酶进行研究。蛋白质免疫印迹分析表明,在人成纤维细胞、人胎盘和非洲绿猴肾细胞提取物中存在一种36 kDa的尿嘧啶-DNA糖基化酶蛋白。有趣的是,这些抗体在仓鼠卵巢(CHO)或小鼠NIH3T3成纤维细胞中未检测到糖基化酶蛋白。在降低严谨性的条件下,对来自人成纤维细胞、人胎盘细胞和非洲绿猴肾细胞的经BamHI消化的DNA进行Southern印迹分析,发现了共同的12 kb和3 kb片段。相比之下,使用相同的降低严谨性方案,分别在CHO和NIH3T3 DNA中看到了6 kb和8 kb片段,以及一个共同的3 kb片段。在更严格的洗涤条件下,在所有分析的样品中均未出现共同的3 kb条带,并且未从仓鼠或小鼠来源的DNA中检测到杂交信号。因此,人类尿嘧啶-DNA糖基化酶与啮齿动物形式之间缺乏免疫反应性在基因水平上也有所体现。人类和CHO杂交模式的这种差异使我们能够通过体细胞杂交将这种人类尿嘧啶-DNA糖基化酶cDNA定位到5号染色体上。